HG002 DRAGEN full single-genome runtime on Phase4
Scoped author-reported evidence candidate; no clinical recommendation.
Overview
Scoped author-reported evidence candidate; no clinical recommendation.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
1 recorded evaluation, 1 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
1 evaluation · 1 result. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: DRAGEN 4.2 on Phase4 SKY-6200 | Protocol: HG002 DRAGEN full single-genome runtime on Phase4 Dataset: HG002 DRAGEN runtime sample | 1840 total_pipeline_runtime seconds · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceDRAGEN HG002 Phase4 full pipeline runtime amp-protocol-dragen-hg002-phase4-total-runtime Aggregation: Not reported Comprehensive genome analysis and variant detection at scale using DRAGEN; DRAGEN supplementary tables 1–17 · Supplementary Tables XLSX sheet 'S1 DRAGEN4.2 Time Metrics', AE20; A20=HG002; A17=Phase4; AE18=Total runtime; A3=seconds; B36:B40 hardware |
Source checking is not independent reproduction. Release 2026-10-07-1448159e6a81.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Recorded evaluations
Each evaluation records what was tested and under which conditions.
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
- Author-reported evaluations
- 1
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Select a task-valid null control after reviewing inputs and metric
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Select an upstream conventional reference after reviewing the full protocol
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV · Model evaluation matrix · Source table · Release and checksums
Coverage is derived from release 2026-10-07-1448159e6a81. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
View linked audit checks and correction history
Release 2026-10-07-1448159e6a81 · Record review: source checked
2 source records and release history
- Comprehensive genome analysis and variant detection at scale using DRAGEN · Original source · 2024-10-25 version of record; code-availability correction 2024-12-02; July 2025 issue
- DRAGEN supplementary tables 1–17 · Original source · MOESM3 XLSX retrieved 2026-10-07
Technical metadata and extraction receipts
Stable ID: amp-protocol-dragen-hg002-phase4-total-runtime
- areas
- dna-genomes
- contexts
- clinical_research
- control
- Same sample on AWS f1.4xlarge, Xeon E5-2686v4 @2.30GHz, 16 threads, RAM (BG)251.0; total 5521.21 seconds at AE7. Hardware comparator, not another model.
- limitations
- Operational baseline for a conventional genomics pipeline; proxy to foundation-model execution workload.; One sample runtime is not cohort throughput, diagnostic report turnaround or demonstrated patient benefit.; Article separately reports ~2h joint aggregation over 3202 genomes at concurrency200, a different operation not assigned to this runtime.
- missing metadata
- memory measurement: No peak-RAM endpoint; replicates: Unreported
- protocol
- Reported total pipeline runtime for the HG002 Phase4 row, Table S1 cell AE20. Use the reported total; do not sum separately reported stage durations. Stage concurrency is not established by this table.
- version
- Table S1 cell AE20